Use access key #2 to skip to page content.
$5.14 -0.29 (-5.34%)
10/3/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar TMFSunshine (43.53) Submitted: 4/18/06 12:16 AM : Outperform Start Price: $10.45 EXEL Score: -37.73

check out the pipeline on that company!

Report this Post Replies: 0 | Reply

Featured Broker Partners